Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.

Show other versions (1)

BACKGROUND: RTS,S/AS01E is the lead candidate malaria vaccine. We recently showed efficacy against clinical falciparum malaria in 5-17 month old children, during an average of 8 months follow-up. We aimed to assess the efficacy of RTS,S/AS01E during 15 months of follow-up. METHODS: Between March, 20...

Full description

Bibliographic Details
Main Authors: Olotu, A, Lusingu, J, Leach, A, Lievens, M, Vekemans, J, Msham, S, Lang, T, Gould, J, Dubois, M, Jongert, E, Vansadia, P, Carter, T, Njuguna, P, Awuondo, K, Malabeja, A, Abdul, O, Gesase, S, Mturi, N, Drakeley, C, Savarese, B, Villafana, T, Lapierre, D, Ballou, W, Cohen, J, Lemnge, M
Format: Journal article
Language:English
Published: 2011

Similar Items